Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
3.360
-0.130 (-3.72%)
May 15, 2026, 4:00 PM EDT - Market closed
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $7.62 million as of May 15, 2026. Its market cap has decreased by -52.33% in one year.
Market Cap
7.62M
Enterprise Value
-1.63M
1-Year Change
-52.33%
Ranking
Category
Stock Price
$3.36
Market Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from $18.49M to $7.62M, a decrease of -58.79%. That is a compound annual growth rate of -4.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 7.62M | -69.08% |
| Dec 31, 2025 | 24.64M | 58.34% |
| Dec 31, 2024 | 15.56M | 75.98% |
| Dec 31, 2023 | 8.84M | -54.56% |
| Dec 29, 2022 | 19.46M | -49.59% |
| Dec 30, 2021 | 38.60M | 34.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CDT Equity | 8.38M |
| Creative Medical Technology Holdings | 8.28M |
| HCW Biologics | 8.22M |
| Evogene | 8.11M |
| Liminatus Pharma | 8.08M |
| Processa Pharmaceuticals | 7.87M |
| Addex Therapeutics | 7.15M |
| BioAtla | 7.08M |